National Center for Tumor Diseases (NCT) Heidelberg
Petra Oberrauch serves as the Scientific Coordinator at the National Center for Tumor Diseases (NCT) Heidelberg since January 2019. Prior to this role, Petra worked as a Consultant at inno AG from September 2011 to December 2018 and as a Research Fellow at Mannheim Centre for European Social Research from September 2010 to August 2011. Petra holds a Master's degree in Politics and Public Administration from the University of Konstanz, a Bachelor's degree in Economics and International Cooperation from Università degli Studi di Firenze, and was an Erasmus exchange student in Economics at Handelshögskolan vid Göteborgs Universitet in 2005.
National Center for Tumor Diseases (NCT) Heidelberg
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here the patients benefit from an individual treatment plan prepared in a timely manner in interdisciplinary expert rounds, the so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. Since 2015, a second site for the NCT beside Heidelberg has been under development in Dresden.